by Mette Bach Dyremose | Apr 7, 2022 | News
Bringing together experts from different disciplines holds a huge potential when it comes to achieving major breakthroughs in science. To drive such interdisciplinary research in male reproduction, the Novo Nordisk Foundation has awarded ReproUnion researcher Kristian...
by Mette Bach Dyremose | Mar 24, 2022 | News
In February 2022 the Journal of the American Heart Association published a study, which associates assisted reproduction with an increased risk of vascular and other complications during pregnancy, especially in women aged 35 years or older and those with pre-existing...
by Mette Bach Dyremose | Mar 14, 2022 | News
At the end of February 2022 Barbara Sahlin successfully defended her PhD, where the results indicate for the first time in healthy men that early effects of testosterone deficiency provoke metabolic changes detected in blood. “I started my study to gain in-depth...
by Mette Bach Dyremose | Jan 14, 2022 | News
On the 14th of December 2021, Camilla Mårtensen cut the ribbon to new top-modern facilities at Reproduktionsmedicinsk centrum (RMC) in Malmö. “RMC plays such an important and meaningful role and in these challenging times for the healthcare sector it is great with the...
by Mette Bach Dyremose | Dec 20, 2021 | News
In the autumn 2021 Bernadette Mannaerts stepped into ReproUnion’s Executive Board with a passion for drug development and a weak spot for the Nordics. “It has been a pleasure to welcome Bernadette to ReproUnion. With over 35 years in the reproductive medicine...
by Mette Bach Dyremose | Nov 5, 2021 | News
The first week of November marks the European Fertility Week – and this year, for the first time ever, it is shedding light on male infertility issues and men’s health. More than 25 million citizens in the European Union are facing fertility issues today with male...
